ELLIPTA inhaler

DEVICE2 trials

Sponsors

GlaxoSmithKline

Conditions

AsthmaPulmonary Disease, Chronic Obstructive

Phase 4

A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT03474081

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2018-03-29End: 2019-07-17Updated: 2021-07-15

Unknown Phase

ELLIPTA™ vs. MDI Inhaler Preference Study, in Adult Subjects With Asthma

CompletedNCT02135718

GlaxoSmithKlineAsthma

Start: 2014-06-30End: 2014-07-31Updated: 2016-06-08